意见反馈 手机随时随地看行情

公司公告

安道麦B:2019年第一季度报告附件(英文版)2019-04-30  

						       ADAMA Q1 Sales Exceed $1 billion for Second Consecutive Year
    Q1 Sales of $1,006 million, slightly below last year’s best-ever, up 1.0% in constant
    currency terms
     Strong growth from Latin America, India, Middle East and Africa, as well as China and new
      joiners Bonide and Anpon
     Weather- and supply-related delays in North America, Europe and Asia-Pacific
     Significant 4.8% price increase across all regions
     Jingzhou old site, which impacted ability to fulfill demand in Q1, gradually resuming operation

    Q1 Gross Profit of $344 million
     Gross margin of 34.2%, in-line with Q1 2018
     Price increases offsetting higher procurement costs and softer currencies

    Q1 EBITDA of $187 million, in-line with last year (in RMB terms, EBITDA increased 5%
    year-on-year)
     EBITDA margin of 18.6%, in-line with last year
     Containment of overall operating expenses, while recording $11m idleness cost of Jingzhou
      old site

    Q1 Net Income of $80 million, $4 million lower than last year (in RMB terms, Net income
    increased 1% year-on-year)
     Net income margin of 8.0%, in-line with last year

    Bonide and Anpon acquisitions concluded


BEIJING, CHINA and TEL AVIV, ISRAEL, April 29, 2019 – Leading global crop protection
company ADAMA Ltd. (the “Company”) (SZSE 000553), today reported its financial results for the
first quarter ended March 31, 2019.

                                                                                            %
                                                                                                            %
 Adjusted, US$ millions                                Q1 2019         Q1 2018            Change
                                                                                                          Change
                                                                                           CER
 Revenues                                                  1,006           1,022           1.0%              -1.6%
 Gross profit                                                 344            352                             -2.3%
   Gross margin                                           34.2%           34.4%
 Operating income (EBIT)                                      127            136                             -6.7%
   EBIT margin                                            12.6%           13.3%
 Net income                                                   80              84                             -4.5%
   Net income margin                                        8.0%           8.2%
 EBITDA                                                       187            190                             -1.4%
   EBITDA margin                                          18.6%           18.6%
 Earnings per share    –   USD                           0.0327          0.0343
                       –   RMB                           0.2207          0.2178

All income statement items contained in this release are presented on an adjusted basis. For a detailed description and
analysis of the differences between the adjusted income statement items and the items as reported in the financial



                                                          1
statements, see “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements” in
the appendix to this release.
Earnings per share are the same for basic and diluted. The number of shares used to calculate earnings per share is
2,446.6 million shares. Q1 2019 includes the results of both Bonide and Anpon following the competion of their acquisition
by the Company during the quarter.



Commenting on the results, Yang Xingqiang, Chairman of ADAMA’s Board of Directors, said,
“ADAMA continues to prove its ability to deliver strong levels of sales and profit, overcoming the
challenging conditions in the market. This demonstrates the strength of the Company’s diversified
and differentiated portfolio and its global commercial footprint. This start to the year positions
ADAMA well to capitalize on its unique set of opportunities to drive further growth.”

Chen Lichtenstein, President and CEO of ADAMA, added, “Our resilient performance this quarter
saw us overcome challenges that the industry is facing, including difficult weather in North America
and Australia and tight supply conditions. Action of our China and global teams ensured that we
were able to quickly resume operations at the old site in Jingzhou, mitigating the impact on supply
going forward."

Performance in Context of Market Environment
Crop prices remain soft, with continued uncertainty surrounding the US-China trade tensions. These
relatively low commodity prices remain challenging for farmer incomes in most regions, resulting in
continued subdued demand for crop protection products.
Severe winter conditions in North America have caused a significant delay in planting, impacting
crop protection application throughout the region. The season is now commencing, and the pace of
temperature rise in the coming weeks will determine how much of the delay can still be captured.
The Company continues to exercise restraint of its manufacturing and other operating costs to
mitigate the impact of continued shortages in certain raw materials and intermediates. The supply
constrained environment, mostly owing to increased environmental focus in China, has seen
procurement costs remain elevated compared to the first quarter of last year, while also contributing
to overall stronger pricing of the Company’s products in its end-markets.

Financial Highlights
Revenues in the first quarter were $1,006 million, slightly below last year’s best-ever; increasing by
1.0% in constant currency terms.
This resilient performance was achieved despite the severe winter in North America and continued
supply constraints globally. ADAMA delivered strong growth in Latin America and Brazil, in India,
Middle East and Africa, as well as high double-digit growth in China excluding products of the
Jingzhou old site.
Strong demand for ADAMA’s differentiated product portfolio facilitated price increases across all
regions, which more than offset the impact of softer currencies.
This overall robust momentum together with joiners Bonide and Anpon, enabled the Company to
overcome the lack of product to fulfill demand due to several weeks of production disruption at the
Jingzhou old site, as well as the harsh winter in North America and continued supply constraints.

Gross profit in the quarter was $344 million (gross margin of 34.2%), compared to $352 million in
the first quarter last year (gross margin of 34.4%). The Company succeeded in maintaining a stable
gross margin mostly due to the strong performance in many geographies including China (excluding
Jingzhou products) and significant price increases.




                                                            2
Operating expenses. Total operating expenses were $218 million (21.6% of sales) in the quarter
compared to $217 million (21.2% of sales) in the first quarter last year. This reflects continued
containment of overall expenses, while recording an $11 million charge for the idleness of the
Jingzhou old site, which now gradually resumes operation, and adding of joiners Bonide and Anpon.

Sales and Marketing expenses in the quarter were $164 million (16.3% of sales), compared to $162
million (15.8% of sales) in the first quarter last year. The moderate increase reflects the inclusion of
expenses of joiners.

General and Administrative expenses in the quarter were $32 million (3.2% of sales) compared to
$38 million (3.7% of sales) in the first quarter last year.

R&D expenses in the quarter were $14 million (1.4% of sales) compared to $13 million (1.2% of
sales) in the first quarter last year.

Other operating expenses net, include the $11 million impact of idle production expenses due to the
suspension of production at the Jingzhou old site.

Operating income in the quarter was $127 million (12.6% of sales), compared to $136 million (13.3%
of sales) in the first quarter last year.

EBITDA in the quarter was $187 million, compared to $190 million in the first quarter last year, with
the EBITDA margin of 18.6%, in-line with first quarter last year.

Financial expenses and investment income. Total net financial expenses and investment income
in the quarter were $37 million compared to $34 million in the first quarter last year. This reflects
somewhat higher debt levels, as well as the adoption of a new accounting standard leading to the
capitalization of operating leases.

Tax expenses. Net tax expenses were $9 million in the quarter, compared to $18 million in the first
quarter last year. The lower expenses were due to lower taxable income generated at the Jingzhou
site as well as seasonally lower locally recorded pre-tax income in Brazil.

Net income in the quarter was $80 million (8.0% of sales) compared to $84 million (8.2% of sales)
achieved in the first quarter last year.

Working capital at March 31, 2019 was $2,082 million, higher by $325 million compared to the
same point last year. The higher level reflects higher trade receivables resulting from the Company’s
strong growth in Q4 2018, inventory build-up at higher procurement costs to prepare for the
expected growth in 2019 and mitigate supply shortages, the delayed season in North America and
additions of joiners’ working capital.

Cash Flow. Operating cash flow of $191 million was consumed in the quarter, compared to $34
million consumed in the corresponding period last year, reflecting the higher working capital.

Net cash used in investing activities was $159 million in the quarter compared to a cash inflow of $7
million in the first quarter last year, with the higher 2019 level also reflecting the acquisition of Bonide,
and the lower 2018 level affected by the one-time proceeds from the divestiture of several products
in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina
last year, and payment of a lesser net amount for the transfer of a similar portfolio of products.

Investments in fixed assets, net of investment grants, amounted to $23 million in the quarter
compared to $27 million in the first quarter last year.



                                                     3
Free cash flow of $355 million was consumed in the first quarter, compared to $31 million consumed
in the first quarter last year, noting the exceptionally lower level in 2018 due to the receipt of an
approximately $379 million one-time cash inflow from the divestiture of products in Europe in
connection with the acquisition of Syngenta by ChemChina last year, and the lower cash amount
paid for the similar portfolio of products transferred to the Company.

Leverage: Balance sheet net debt at the end of the quarter was $875 million compared to net debt
of $513 million as of March 31, 2018, reflecting mostly the sum of the acquisition payment for Bonide,
assumption of acquired Anpon’s debt and the dividend paid in 2018.

Jingzhou Old Site
The Jingzhou old site is gradually resuming operation, following its connection via pipeline to the
state-of-the-art wastewater treatment facility installed at the new and already operational site. As a
consequence of the disruption, the Company lacked sufficient product to fulfill first quarter demand,
and incurred approximately $11 million of additional idleness cost, reflected in operating expenses.
The impact of the suspension is expected to continue to some extent into the second quarter, and
subside alongside the increase in output at the old site.

Regional Sales Performance

                                                Q1 2019       Q1 2018          Change        Change
                                                  $m            $m              CER           USD

Europe                                             360           393            -11.1%         -8.3%

North America                                      180           194             -6.8%         -7.1%

Latin America                                      159           139           +25.9%        +14.6%

Asia Pacific                                       186           188            +2.9%          -1.4%

Of which China                                      94             84          +14.3%        +11.2%

India, Middle East & Africa                        121           108           +23.9%        +11.8%

  Total                                           1,006         1,022           +1.0%          -1.6%
CER: Constant Exchange Rates



Europe: Sales in Europe were lower by 11.1% in the quarter in constant currency terms,
compared to the first quarter last year. This is primarily due to tight supply conditions, especially in
intermediates procured from China, which constrained sales in key countries across the region.
The reduced sales were partially offset by price increases.
In Northern Europe, sales were also impacted by challenging credit conditions in Ukraine, with the
Company proactively restricting sales to those customers with a proven ability to pay. In Southern
Europe, sales were impacted by a reduction in herbicides due to lower oilseed rape planted areas.
In the quarter, ADAMA launched GIGANT in Germany and PRIZM in the UK, a distinctive
fungicide mixture delivering long-lasting, broad-spectrum protection in wheat and barley. The
Company obtained several new product registrations in the quarter, including MAVRIK JET, an
effective, fast-acting contact insecticide for the control of aphids in oilseed rape in France, as well
as EMBRELIA, a combination fungicide with dual mechanism of action for fruit in Portugal.
In US dollar terms, sales in Europe were lower by 8.3% in the quarter compared with the first
quarter last year, with the Company successfully hedging its exposure to the European currencies
which softened over the period.


                                                    4
North America: Sales in North America were lower by 6.8% in the quarter in constant currency
terms, compared with the first quarter last year, with the impact of the severe winter being partially
offset by increased prices.
The extremely cold and wet conditions have delayed the planting season and disrupted
transportation lines, impacting sales in both crop and non-crop markets and slowing movement
through distribution channels.
In the Consumer and Professional Solutions space, Bonide performed well in its first quarter since
acquisition.
ADAMA launched BRAZEN, a selective herbicide for grass control in spring wheat and barley in
Canada.
In US dollar terms, sales in North America were lower by 7.1% in the quarter compared to the first
quarter last year.

Latin America: Sales in Latin America grew by a significant 25.9% in the quarter in constant
currency terms, compared with the first quarter last year, with robust business growth across the
region, alongside higher prices in the face of continued constrained supply.
ADAMA saw noteworthy performances in Brazil, Argentina and Mexico. In Brazil, the strong growth
was led by continued strong demand for the Company’s differentiated portfolio including
CRONNOS, as well as for NIMITZ and ExpertGrow, despite drought conditions in key regions.
The Company also saw a strong performance of its cotton portfolio, benefiting from an increase in
planted areas.
The Company continues to develop its differentiated portfolio in the region. In Brazil, ADAMA
launched TRIVOR, a differentiated insecticide combination providing rapid and extended control
of white flies in several crops, and obtained registration for COMISSARIO, an insecticide for
controlling sucking pests in cotton. The Company also launched CRONNOS in Bolivia and
obtained registrations for the NIMITZ suite of products in Peru.
In US dollar terms, sales in Latin America increased by 14.6% in the quarter compared with the
first quarter last year, reflecting the softening of local currencies.

Asia-Pacific: Sales in the region grew by 2.9% in the quarter in constant currency terms,
compared with the first quarter last year.
In China, ADAMA grew in the quarter by 14.3%, and continues to see strong demand for its
differentiated, formulated and branded products, and prioritizes the sale of these products through
its own channels by rapidly shifting away from selling unformulated, technical product to
intermediaries, and in so doing benefiting from the full product positioning as well as end-to-end
margin. Sales of these formulated, branded products grew strongly in the quarter by high double-
digit percent excluding those of the suspended Jingzhou old site.
ADAMA continues to make significant portfolio advances in China, including bringing flagship
ADAMA global brands to the country. The first quarter saw the launch of AGIL, a systemic
herbicide for selective weed control of a wide range of grasses in many broadleaf crops as well as
GALIL, a differentiated insecticide mixture for rice.
Anpon performed well in its first quarter since acquisition.
While the Company saw a strong performance in Thailand, the continued severe drought in
Australia reduced summer crop production in the country by an estimated 30%, impacting sales in
the quarter.
During the quarter, the Company obtained a number of new registrations for differentiated products,
including AGROSY, a herbicide for ryegrass and seed clover and APHIDEX, an insecticide for
aphid control in fruit, cereal and vegetable, both in New Zealand, as well as MANDATE XTRA, a

                                                    5
selective grass herbicide for cereals, and QUADRANT, a four-way combination herbicide for
broadleaf weeds in winter cereals, both in Australia.
In US dollar terms, sales were lower by 1.4% in the quarter compared to the first quarter last year,
reflecting the impact of softer currencies in the region.

India, Middle East & Africa: Sales grew by a significant 23.9% in the quarter in constant currency
terms, compared with the first quarter last year. This strong performance resulted from a
combination of strong, double-digit business growth, alongside higher prices.
ADAMA delivered high growth in Turkey, where its business continues to gain significant market
share. The Company continues to grow strongly in India, despite the lingering impact of the late
2018 drought conditions, while dry conditions in South Africa impacted sales in the country.
In US dollar terms, sales were higher by 11.8% in the quarter compared to the first quarter last
year, reflecting the impact of softer currencies over the period.

Revenues by operating segment
First quarter sales

                                               Q1 2019                        Q1 2018
                                                                %                              %
                                               USD(m)                         USD(m)

Crop Protection                                     910         90.4%             948         92.7%

Intermediates and Ingredients                          97        9.6%              74          7.3%

Total                                             1,006         100%             1,022         100%



Further Information
All filings of the Company, together with a presentation of the key financial highlights of the period,
can be accessed through the Company website at www.adama.com.


##
About ADAMA
ADAMA Ltd. is one of the world's leading crop protection companies. We strive to Create Simplicity
in Agriculture – offering farmers effective products and services that simplify their lives and help
them grow. With one of the most comprehensive and diversified portfolios of differentiated, quality
products, our more than 7,000-strong team reaches farmers in over 100 countries, providing them
with solutions to control weeds, insects and disease, and improve their yields. For more information,
visit us at www.ADAMA.com and follow us on Twitter at @ADAMAAgri.


Contact
Ben Cohen                                 Zhujun Wang
Global Investor Relations                 China Investor Relations
Email: ir@adama.com                       Email: irchina@adama.com




                                                   6
Abridged Consolidated Financial Statements
The following abridged consolidated financial statements and notes have been prepared as
described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all
of the information which either PRC GAAP or IFRS would require for a complete set of financial
statements and should be read in conjunction with the consolidated financial statements of both
ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock
Exchanges, respectively.

Abridged Consolidated Income Statement for the First Quarter
                                                           Q1 2019           Q1 2018            Q1 2019            Q1 2018
Adjusted1
                                                           USD(m)            USD(m)             RMB(m)             RMB(m)

Revenues                                                    1,006              1,022                6,788              6,500
Cost of Sales                                                 659                667                4,442              4,241
Business taxes and surcharges                                    4                   3                 25                 19
Gross profit                                                  344                352                2,321              2,239
% of revenue                                               34.2%              34.4%                34.2%              34.4%
     Selling and distribution expenses                        164              162                  1,103              1,027
     General and administrative expenses                       32                 38                  217                242
     Research and development expenses                         14                 13                   96                 80
     Other                                                       8                   4                 52                 28
Total Operating expenses                                      218                216                1,468              1,377
Operating income (EBIT)                                       127                136                  853                862
% of revenue                                               12.6%              13.3%                12.6%              13.3%
Financial expenses and investment income                        37                34                  252                216
Income before taxes                                             89               102                  601                646
Taxes on Income                                                  9                18                   61                113
Net income                                                      80                84                  540                533
% of revenue                                                 8.0%              8.2%                 8.0%                8.2%
EBITDA                                                        187                190                1,264              1,208
% of revenue                                               18.6%              18.6%                18.6%              18.6%

Earnings per Share – Basic                                0.0327             0.0343              0.2207              0.2178
                           – Diluted                      0.0327             0.0343              0.2207              0.2178

Earnings per share are the same for basic and diluted. The number of shares used to calculate earnings per share is
2,446.6 million shares.




1
    For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the
    financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.




                                                                     7
Abridged Consolidated Balance Sheet

                                           March 31       March 31   March 31   March 31
                                            2019           2018       2019       2018
                                           USD (m)        USD (m)    RMB (m)    RMB (m)
Assets
 Current assets:
   Cash at bank and on hand                     713            891      4,801       5,605
   Bills and accounts receivable              1,344          1,018      9,052       6,398
   Inventories                                1,482          1,247      9,979       7,844
   Other current assets, receivables and
                                               290            394       1,949       2,475
   prepaid expenses
   Total current assets                       3,829          3,550     25,781     22,323
  Non-current assets:
   Fixed assets, net                          1,213          1,076      8,171       6,763
   Intangible assets, net                     1,497          1,518     10,077       9,547
   Deferred tax assets                          119            114        801         731
   Other non-current assets                     100             80        674         503
   Total non-current assets                   2,929          2,789     19,723     17,544
Total assets                                  6,758          6,339     45,504     39,866

Liabilities
  Current liabilities:
   Loans and credit from banks and
                                               390            134       2,627        845
   others
   Bills and accounts payable                  767            739       5,163       4,646
   Other current liabilities                   796            752       5,358       4,726
   Total current liabilities                  1,953          1,625     13,148     10,217
  Long-term liabilities:
   Long-term loans                               70             75        472         472
   Debentures                                 1,147          1,171      7,723       7,363
   Deferred tax liabilities                      56             69        380         435
   Employee benefits                             87             95        588         595
   Other long-term liabilities                  141             74        950         466
   Total long-term liabilities                1,502          1,484     10,113       9,330
Total liabilities                             3,455          3,109     23,261     19,547

Equity
   Total equity                               3,304          3,230     22,243     20,319
   Total equity                               3,304          3,230     22,243     20,319
Total liabilities and equity                  6,758          6,339     45,504     39,866




                                                      8
Abridged Consolidated Cash Flow Statement for the First Quarter

                                                            Q1 2019   Q1 2018   Q1 2019   Q1 2018
                                                            USD (m)   USD (m)   RMB (m)   RMB (m)

Cash flow from operating activities:
   Cash flow from operating activities                        -191       -34    -1,232      -216
Cash flow from operating activities                           -191       -34    -1,232      -216

Investing activities:
    Acquisitions of fixed and intangible assets                -43      -373      -321    -2,374
    Proceeds from disposal of fixed and intangible assets        5       379        31     2,412
    Acquisitions of a subsidiary                              -122         -      -825         -
    Other investing activities                                   1         1        10         7
Cash flow used for investing activities                       -159         7    -1,105       46

Financing activities:
    Receipt of loans from banks and other lenders              228         -     1,358         -
    Repayment of loans from banks and other lenders            -38      -289      -110    -1,836
    Other financing activities                                 -66        -8      -426       -50
Cash flow from (used for) financing activities                 124      -297      823     -1,886
Effects of exchange rate movement on cash and cash               5        10       -78      -211
equivalents
Net change in cash and cash equivalents                       -221      -313    -1,593    -2,267
Cash and cash equivalents at the beginning of the period       925     1,204     6,043     7,864
Cash and cash equivalents at the end of the period             704       890     4,450     5,597


Free Cash Flow                                                -355       -31    -2,371      -196




                                                       9
Notes to Abridged Consolidated Financial Statements

Note 1: Basis of preparation

Basis of presentation and accounting policies: The abridged consolidated financial statements for the
quarters ended March 31, 2019 and 2018 incorporate the financial statements of ADAMA Ltd. and of all of its
subsidiaries (the “Company”), including Adama Agricultural Solutions Ltd. (“Solutions”) and its subsidiaries.
The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of
Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or
revised subsequently by the MoF (collectively referred to as "CASBE").
The abridged consolidated financial statements contained in this release are presented in both Chinese
Renminbi (RMB), as the Company’s shares are traded on the Shenzhen Stock Exchange, as well as in United
States dollars ($) as this is the major currency in which the Company’s business is conducted. For the
purposes of this release, a customary convenience translation has been used for the translation from RMB to
US dollars, with Income Statement and Cash Flow items being translated using the quarterly average
exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.

The preparation of financial statements requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimated.

Note 2: Abridged Financial Statements
For ease of use, the Financial Statements shown in this release have been abridged as follows:

Abridged Consolidated Income Statement:
        “Operating expenses” includes selling and distribution expenses; general and administrative expenses;
        research and development expenses; asset and credit impairment losses; gain (loss) from disposal of
        assets and non-operating income and expenses
        “Financial expenses and investment income” includes net financing expenses; gains from changes in
        fair value; and investment income (including share of income of equity accounted investees)

Abridged Consolidated Balance Sheet:
        “Other current assets, receivables and prepaid expenses” includes financial assets held for trading,
        derivatives financial assets, prepayments, other receivables; and other current assets
        “Fixed assets, net” includes fixed assets, construction in progress and rights-of-use assets
        “Intangible assets, net” includes intangible assets and goodwill
        “Other non-current assets” includes other equity investments; long-term equity investments; long-term
        receivables; investment property; and other non-current assets
        “Loans and credit from banks and others” includes short-term loans and non-current liabilities due
        within one year
        “Other current liabilities” includes derivatives financial liabilities, payables for employee benefits,
        contract liabilities, taxes payable, other payables and other current liabilities
        “Other long-term liabilities” includes long-term payables, lease liability, provisions and other non-
        current liabilities




                                                       10
Analysis of Gaps between Adjusted Income Statement and Reported
Income Statement in Financial Statements
               Q1                 Adjusted                         Adjustments                   Reported
             USD(m)       Q1 2019          Q1 2018           Q1 2019        Q1 2018      Q1 2019          Q1 2018
Revenues                      1,006            1,022                  -             -        1,006            1,022
Gross profit                    344              352                  1             1          343              351
Operating expenses              218              216                -29           305          247              -88
Operating income (EBIT)         127              136                 30          -303           97              439
Income before taxes              89              102                 28          -303           61              405
Net income                       80               84                 26          -236           54              320
EBITDA                          187              190                  5          -312          183              502
Earnings per share           0.0327            0.0343                                       0.0222            0.1307

              Q1                 Adjusted                          Adjustments                  Reported
            RMB(m)        Q1 2019           Q1 2018          Q1 2019        Q1 2018      Q1 2019           Q1 2018
Revenues                      6,788             6,500                 -              -       6,788             6,500
Gross profit                  2,321             2,239                7               9       2,314             2,230
Operating expenses            1,468             1,377             -195           1,938       1,663              -561
Operating income (EBIT)         853               862              202          -1,929         651             2,791
Income before taxes             601               646              186          -1,929         415             2,575
Net income                      540               533              173          -1,499         367             2,032
EBITDA                        1,264             1,208               32          -1,985       1,232             3,193
Earnings per share           0.2207            0.2178                                       0.1499            0.8306




                                                        11
Income Statement Adjustments
In addition to the reported financial results that the Company prepares in accordance with PRC GAAP, the
Company’s management prepares non-GAAP, Adjusted financial results to present what the Company
believes is a more useful view of the true economic performance of the business on an ongoing basis. These
Adjusted results exclude items that are of a one-time or non-cash/non-operational nature that do not impact
the ongoing performance of the business and reflects the way the Company’s management and Board of
Directors view the performance of the Company. The Company believes that excluding the effects of these
items from its operating results allows an effective assessment and comparison of the underlying financial
performance of its business from period to period and within the market.



                                                                                    Q1 2019        Q1 2018            Q1 2019       Q1 2018
                                                                                    USD (m)        USD (m)            RMB (m)       RMB (m)
     Net Income (Reported)                                                              54.4         319.6              366.8        2,032.2
       Adjustments to COGS & Operating Expenses:
      1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-              11.5           11.5              77.2           72.8
           cash)
      2. One-time capital gain from Divestment of registrations due to 2017                -         -314.3                  -      -1,998.5
           ChemChina-Syngenta transaction
      3. Amortization of Transfer assets received and written-up due to 2017            10.6              -              71.7               -
           ChemChina-Syngenta transaction (non-cash)
      4. Reinstatement of amortization expenses due to Divestment (non-                    -           -2.6                  -         -16.5
           cash)
      5. Accelerated depreciation due to relocation (non-cash)                           2.3              -              15.5              -
      6. Non-core assets closure (non-cash)                                                -            1.6                 -            9.9
      7. Long-term incentive classified on an equity-settled basis (non-cash)            4.7           -0.9              31.9           -5.9
      8. Amortization of acquisition PPA (non-cash)                                      0.9              -               6.1              -
      9. Sanonda-ADAMA Combination transaction one-time stamp tax                          -            1.5                 -            9.4
     Total Adjustments to Operating Income (EBIT)                                       30.0         -303.4             202.4       -1,928.7
     Total Adjustments to EBITDA                                                         4.7         -312.2              31.9       -1,985.0
      Adjustments to Financing Expenses:
      10. Revaluation of non-cash adjustment related to non-controlling                 -2.4              -             -16.1               -
           interest
     Total Adjustments to Income before Taxes                                           27.6         -303.4             186.4       -1,928.7
      Adjustments to Taxes
      1. Tax shield on Legacy PPA of 2011 acquisition of Solutions                      -1.9           -1.9             -13.1          -12.4
      2. Tax expense due to capital gain from registrations Divestment                     -           69.5                 -          441.8
     Total adjustments to Net Income                                                    25.7         -235.9             173.2       -1,499.3
     Net Income (Adjusted)                                                              80.1           83.8             540.0          532.8


Notes:
 1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical
     “legacy” amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition
     of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the
     second half of 2020.
 2. One-time capital gain from Divestment of registrations due to 2017 ChemChina-Syngenta transaction: In the first quarter of 2018, the
     Company earned a one-time profit on the Divestment of crop protection products in connection with the approval by the EU Commission of the
     acquisition of Syngenta by ChemChina. This one-time profit is excluded from the Adjusted financial results due to its one-time nature, while the
     related tax expense is also adjusted for.
 3. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from
     the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by
     ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of
     similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value
     as those divested, and since the Company excludes the one-time gain that it made on the divested products, the additional amortization charge


                                                                         12
      incurred due to the written-up of the acquired assets is also excluded to present a consistent view of Divestment and Transfer transactions,
      which had no net impact on the underlying economic performance of the Company. See note 2.
4.    Reinstatement of amortization expenses, related to the Divestment (non-cash): Reinstatement of amortization expenses due to
      classification of to-be-divested European registrations as “Held-for-Sale”, related to 2017 ChemChina acquisition of Syngenta.
5.    Accelerated depreciation due to relocation (non-cash): Production assets located in the old production sites in Jingzhou and Huai’An will
      be relocated to the new sites in the coming years. Since some of the older production assets may not be able to be relocated, some of these
      assets which are no longer operational are being written off (or impaired), while for others, their economic life has been shortened and
      therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer
      production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for
      the impact of the accelerated depreciation of these assets.
6.    Non-core assets closure (non-cash): One-time charge due to closure of peripheral, non-material assets.
7.    Long-term incentive classified on an equity-settled basis (non-cash): The Company granted its employees, who are mainly non-Chinese
      residents, a long term incentive (LTI) in the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to
      non-Chinese employees. As such, the Company records an expense, or recognizes income, depending on the fluctuation in the Company’s
      share price, even though the Company will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such
      share price movements on the measurement of the Company’s performance and expected employee compensation, in the Company’s
      adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the plan at the grant date.
8.    Amortization of acquisition PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of acquisitions, in
      addition to the full reflection of the purchase price paid in the Company's Net Debt; has no impact on the ongoing performance of the
      companies acquired.
9.    Sanonda-ADAMA Combination transaction one-time stamp tax: One-time stamp tax expense incurred related to the Combination.
10.   Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part
      of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of
      the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of
      Solutions by the Company in 2017, which is treated from an accounting perspective as a “Business Combination Under Common Control”,
      such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no
      bearing on the ongoing performance of the Company and are therefore adjusted for.




                                                                          13
Exchange Rate Data for the Company's Principal Functional
Currencies

                                  March 31                      Q1 Average

                          2019     2018      Change     2019       2018      Change

 EUR/USD                  1.123    1.232      (8.8%)    1.136     1.229       (7.6%)

 USD/BRL                  3.897    3.324     (17.2%)    3.771     3.244      (16.2%)

 USD/PLN                  3.837    3.414     (12.4%)    3.790     3.400      (11.5%)

 USD/ZAR                  14.64    11.82     (23.9%)   14.018    11.945      (17.4%)

 AUD/USD                  0.708    0.768      (7.8%)    0.713     0.786       (9.4%)

 GBP/USD                  1.303    1.407      (7.4%)    1.302     1.391       (6.4%)

 USD/ILS                  3.632    3.514      (3.4%)    3.644     3.458       (5.4%)

 USD LIBOR 3M            2.60%     2.03%      28.4%    2.69%      1.81%       48.5%



                                  March 31                      Q1 Average

                          2019     2018      Change     2019       2018      Change

 USD/RMB                  6.734    6.288       7.1%     6.744     6.358        6.1%

 EUR/RMB                  7.561    7.746      (2.4%)    7.660     7.813       (2.0%)

 RMB/BRL                  0.579    0.529      (9.5%)    0.559     0.510       (9.6%)

 RMB/PLN                  0.570    0.543      (4.9%)    0.562     0.535       (5.1%)

 RMB/ZAR                  0.570    1.789      68.2%     2.079     1.838      (13.1%)

 AUD/RMB                  4.770    4.831      (1.3%)    4.806     4.999       (3.8%)

 GBP/RMB                  8.774    8.847      (0.8%)    8.784     8.843       (0.7%)

 RMB/ILS                  0.539    0.559       3.5%     0.540     0.544        0.7%




                                   14